These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11400182

  • 1. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
    Wardas J, Konieczny J, Lorenc-Koci E.
    Synapse; 2001 Aug; 41(2):160-71. PubMed ID: 11400182
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats.
    Wardas J.
    Pol J Pharmacol; 2003 Aug; 55(2):155-64. PubMed ID: 12926542
    [Abstract] [Full Text] [Related]

  • 3. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
    Pinna A, Fenu S, Morelli M.
    Synapse; 2001 Mar 01; 39(3):233-8. PubMed ID: 11284438
    [Abstract] [Full Text] [Related]

  • 4. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats.
    Ossowska K, Konieczny J, Wolfarth S, Pilc A.
    Neuropharmacology; 2005 Sep 01; 49(4):447-55. PubMed ID: 15919101
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats.
    Lorenc-Koci E, Wolfarth S.
    Eur J Pharmacol; 1999 Nov 26; 385(1):39-46. PubMed ID: 10594343
    [Abstract] [Full Text] [Related]

  • 6. (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats.
    Lorenc-Koci E, Wardas J, Wolfarth S, Pilc A.
    Brain Res; 2001 Jun 08; 903(1-2):177-84. PubMed ID: 11382401
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
    Carta AR, Pinna A, Cauli O, Morelli M.
    Synapse; 2002 Jun 01; 44(3):166-74. PubMed ID: 11954048
    [Abstract] [Full Text] [Related]

  • 8. Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.
    Morelli M, Pinna A.
    Neurol Sci; 2001 Feb 01; 22(1):71-2. PubMed ID: 11487207
    [Abstract] [Full Text] [Related]

  • 9. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Pinna A, Pontis S, Borsini F, Morelli M.
    Synapse; 2007 Aug 01; 61(8):606-14. PubMed ID: 17476684
    [Abstract] [Full Text] [Related]

  • 10. Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug.
    Ossowska K, Konieczny J, Lorenc-Koci E, Schulze G, Coper H, Wolfarth S.
    J Physiol Pharmacol; 1998 Jun 01; 49(2):311-7. PubMed ID: 9670114
    [Abstract] [Full Text] [Related]

  • 11. N-oleoyl-dopamine decreases muscle rigidity induced by reserpine in rats.
    Konieczny J, Przegalinski E, Pokorski M.
    Int J Immunopathol Pharmacol; 2009 Jun 01; 22(1):21-8. PubMed ID: 19309549
    [Abstract] [Full Text] [Related]

  • 12. The role of striatal adenosine A2A receptors in regulation of the muscle tone in rats.
    Wardas J, Konieczny J, Lorenc-Koci E.
    Neurosci Lett; 1999 Dec 03; 276(2):79-82. PubMed ID: 10624796
    [Abstract] [Full Text] [Related]

  • 13. L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats.
    Konieczny J, Ossowska K, Schulze G, Coper H, Wolfarth S.
    Psychopharmacology (Berl); 1999 Apr 03; 143(3):235-43. PubMed ID: 10353425
    [Abstract] [Full Text] [Related]

  • 14. Biomechanical and electromyogram characterization of neuroleptic-induced rigidity in the rat.
    Wu YN, Hyland BI, Chen JJ.
    Neuroscience; 2007 Jun 15; 147(1):183-96. PubMed ID: 17507166
    [Abstract] [Full Text] [Related]

  • 15. The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of l-dopa in unilaterally 6-OHDA-lesioned rats.
    Rose S, Ramsay Croft N, Jenner P.
    Brain Res; 2007 Feb 16; 1133(1):110-4. PubMed ID: 17196564
    [Abstract] [Full Text] [Related]

  • 16. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
    Wardas J, Pietraszek M, Dziedzicka-Wasylewska M.
    Brain Res; 2003 Jul 11; 977(2):270-7. PubMed ID: 12834887
    [Abstract] [Full Text] [Related]

  • 17. Effect of free radicals on adenosine A(2A) and dopamine D2 receptors in the striatum of young adult and aged rats.
    Alfaro TM, Vigia E, Oliveira CR, Cunha RA.
    Neurochem Int; 2004 Oct 11; 45(5):733-8. PubMed ID: 15234116
    [Abstract] [Full Text] [Related]

  • 18. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    Exp Neurol; 2004 Sep 11; 189(1):182-8. PubMed ID: 15296848
    [Abstract] [Full Text] [Related]

  • 19. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Synapse; 2006 Sep 01; 60(3):239-50. PubMed ID: 16739115
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
    Trevitt J, Kawa K, Jalali A, Larsen C.
    Pharmacol Biochem Behav; 2009 Nov 01; 94(1):24-9. PubMed ID: 19602422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.